Invesco Biotechnology & Genome ETF (PBE) Holdings List

$80.70 +0.31 (+0.39%)

As of 04:10 PM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include United Therapeutics, Illumina, and Regeneron Pharmaceuticals. The top 25 PBE holdings ordered by weight make up 89.46% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	UTHR United Therapeutics	$572.20 -1.6%	6.21%	27,386
2	ILMN Illumina	$139.07 -0.2%	5.39%	105,506
3	REGN Regeneron Pharmaceuticals	$702.45 -1.0%	5.04%	16,792
4	BIIB Biogen	$189.13 +1.0%	4.90%	66,449
5	INCY Incyte	$97.47 +0.3%	4.85%	128,319
6	ALNY Alnylam Pharmaceuticals	$301.11 +1.1%	4.76%	38,954
7	AMGN Amgen	$329.59 +1.8%	4.66%	33,867
8	GILD Gilead Sciences	$133.48 +0.6%	4.58%	87,826
9	TGTX TG Therapeutics	$36.10 +1.1%	3.39%	231,817
10	BCRX BioCryst Pharmaceuticals	$9.03 -1.8%	3.32%	929,396
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	ARWR Arrowhead Pharmaceuticals	$74.93 -1.9%	3.28%	111,084
12	PTGX Protagonist Therapeutics	$99.21 -0.3%	3.24%	80,933
13	CPRX Catalyst Pharmaceuticals	$30.86 +6.6%	3.20%	292,381
14	CDNA CareDx	$20.70 -1.2%	3.12%	367,413
15	RPRX Royalty Pharma	$50.44 +0.5%	3.08%	155,787
16	EXEL Exelixis	$44.42 +0.6%	2.81%	156,684
17	PTCT PTC Therapeutics	$65.04 -0.7%	2.80%	102,533
18	NBIX Neurocrine Biosciences	$135.06 +0.7%	2.76%	54,006
19	VCYT Veracyte	$32.97 -1.4%	2.72%	198,169
20	TECH Bio-Techne	$56.68 +3.5%	2.66%	122,788
21	VCEL Vericel	$36.81 +0.9%	2.63%	184,908
22	HALO Halozyme Therapeutics	$65.87 +2.0%	2.63%	100,522
23	ACAD ACADIA Pharmaceuticals	$22.35 +0.7%	2.52%	287,625
24	RGEN Repligen	$125.61 +6.3%	2.47%	52,519
25	TBPH Theravance Biopharma	$16.73 -1.1%	2.44%	371,076

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 95.6%, followed by Cayman Islands at 2.5%.

United States
95.6%
Cayman Islands
2.5%
Netherlands
2.0%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
98.1%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 98.1%.

Health Care
98.1%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 81.2%, followed by Health Care Equipment & Supplies at 16.9%.

Biotechnology
81.2%
Health Care Equipment & Supplies
16.9%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 81.2%, followed by Life Sciences Tools & Services at 13.8%.

Biotechnology
81.2%
Life Sciences Tools & Services
13.8%
Health Care Equipment
3.1%

Related Companies and Tools

Related Companies

This page (NYSEARCA:PBE) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List